{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:05:05Z","timestamp":1790744705430,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with metabolic, anthropometric, and nutritional characteristics. The Nutritional Metabolic Risk Index (NMRI) integrates these dimensions, but its association with MASLD remains unclear. We evaluated the association of the NMRI with prevalent MASLD and its discriminative performance in a sub-plateau population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included 1,551 adults undergoing health examinations at approximately 1,900 m. K-means clustering was used to identify metabolic\u2013nutritional profiles. Associations of NMRI with prevalent MASLD were assessed using multivariable logistic regression and restricted cubic splines. Discriminative and incremental performance were evaluated using receiver operating characteristic curves, net reclassification improvement (NRI), integrated discrimination improvement (IDI), and decision curve analysis, with bootstrap internal validation. Weighted quantile sum (WQS) regression assessed the relative statistical contributions of NMRI components.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three metabolic\u2013nutritional profiles were identified. Compared with the favorable metabolic profile, the adiposity-predominant and unfavorable metabolic\u2013nutritional profiles had higher odds of MASLD (adjusted ORs, 6.62 and 7.85, respectively; both P&amp;lt;0.001). NMRI was inversely associated with prevalent MASLD (adjusted OR per unit increase, 0.71; 95% CI, 0.68\u20130.74), with an approximately linear association. NMRI showed higher discrimination than its individual components. Adding NMRI to the basic model improved discrimination (AUC, 0.822), reclassification (NRI, 0.759; IDI, 0.164), and net benefit across most examined threshold probabilities. Bootstrap validation yielded an optimism-corrected AUC of 0.815. WQS analysis assigned larger weights to TyG and WHtR than to GNRI. Associations remained consistent across subgroup and sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher NMRI was consistently associated with lower odds of prevalent MASLD and showed favorable within-sample discrimination in this sub-plateau population. These findings support further evaluation of NMRI as a parsimonious composite indicator integrating nutritional, metabolic, and anthropometric characteristics associated with MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1952423","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:51:55Z","timestamp":1790743915000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of the nutritional metabolic risk index with metabolic dysfunction-associated steatotic liver disease in a sub-plateau population"],"prefix":"10.3389","volume":"17","author":[{"given":"Huanqiong","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Foshan University Affiliated Third Hospital","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"He","sequence":"additional","affiliation":[{"name":"Department of Health Management Center, First Affiliated Hospital of Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guosong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Northeast Yunnan Central Hospital; Northeast Yunnan Hospital of Kunming Medical University, Northeast Yunnan Clinical School of Kunming Medical University","place":["Zhaotong, Yunnan, China"]},{"name":"Kunming Medical University","place":["Kunming, Yunnan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital of Kunming Medical University","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Foshan University Affiliated Third Hospital","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Foshan University Affiliated Third Hospital","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(25)00226-2","article-title":"Overlooked determinants and unequal outcomes: rethinking metabolic dysfunction-associated steatotic liver disease beyond the biomedical model","volume":"10","author":"Iruzubieta","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70020","article-title":"Addressing the high and rising global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): from the growing prevalence to payors' perspective","volume":"61","author":"Younossi","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/dom.70659","article-title":"Obesity and metabolic dysfunction-associated steatotic liver disease (MASLD): a literature review on pathophysiology and treatment","volume":"28","author":"Romanos","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.19615","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults: a review","volume":"335","author":"Tilg","year":"2026","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16075","article-title":"Clinical outcomes of MAFLD versus NAFLD: a meta-analysis of observational studies","volume":"44","author":"Pennisi","year":"2024","journal-title":"Liver Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3892\/ijmm.2025.5668","article-title":"Metabolic dysfunction-associated steatotic liver disease: pathogenesis, model and treatment (Review)","volume":"56","author":"Ma","year":"2025","journal-title":"Int J Mol Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7555\/jbr.38.20240387","article-title":"Molecular pathways in cardiovascular disease under hypoxia: mechanisms, biomarkers, and therapeutic targets","volume":"39","author":"Abdullaev","year":"2025","journal-title":"J BioMed Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-025-01069-8","article-title":"The impact of high altitude (hypobaric hypoxia) on insulin resistance in humans","volume":"81","author":"Adeva-Andany","year":"2025","journal-title":"J Physiol Biochem"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/antiox15030378","article-title":"A review of HIF-1\u03b1-mediated integration of metabolic reprogramming, mitochondrial function, and PI3K\/Akt-MAPK-Nrf2-NF-\u03baB signaling","volume":"15","author":"Ashraf","year":"2026","journal-title":"Antioxidants (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000548503","article-title":"HIF-1\u03b1 regulates the progression of metabolic dysfunction-associated steatotic liver disease","author":"Liu","year":"2025","journal-title":"Digestion"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2026.1779019","article-title":"Hypoxia-inducible factors in the immunometabolism of metabolic dysfunction-associated steatotic liver disease (MASLD): molecular mechanisms and therapeutic implications","volume":"17","author":"Zhao","year":"2026","journal-title":"Front Physiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120551","article-title":"Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease","volume":"411","author":"Kyhl","year":"2025","journal-title":"Atherosclerosis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000298","article-title":"Multiscale integrative analyses unveil immune-related diagnostic signature for the progression of MASLD","volume":"7","author":"Bai","year":"2023","journal-title":"Hepatol Commun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7119","DOI":"10.1038\/s41598-025-88478-3","article-title":"Association between TyG-related parameters and NAFLD risk in Japanese non-obese population","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003576","article-title":"Decoding the triglyceride-glucose index in metabolic dysfunction-associated steatotic liver disease: integrative insights from Mendelian randomization, cross-tissue transcriptomics, and spatial multi-omics","volume":"112","author":"Wei","year":"2026","journal-title":"Int J Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1726212","article-title":"Analysis of the correlation and discriminative performance of GNRI, CONUT, and PNI with MASLD in Chinese adult physical examination population","volume":"13","author":"Cheng","year":"2026","journal-title":"Front Nutr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-024-00580-1","article-title":"Strengths and limitations of BMI in the diagnosis of obesity: what is the path forward","volume":"13","author":"Sweatt","year":"2024","journal-title":"Curr Obes Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2024.07.004","article-title":"The nutritional metabolic risk index as a predictor of all-cause and cardiovascular mortality: a national cohort study","volume":"63","author":"Zhao","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017\u2014Part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/82.4.777","article-title":"Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients","volume":"82","author":"Bouillanne","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12933-025-02919-x","article-title":"The association between triglyceride glucose-waist height ratio index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study","volume":"24","author":"Lv","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03266-1","article-title":"Optimizing early triage for subclinical cardiovascular-kidney-metabolic syndrome: longitudinal associations, incremental value, and clinical utility of nine insulin resistance surrogates","volume":"25","author":"Huang","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i23.7392","article-title":"Radiologic evaluation of nonalcoholic fatty liver disease","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70087","article-title":"Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population-based study","volume":"6","author":"Zeng","year":"2025","journal-title":"MedComm(2020)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1760","article-title":"Association of metabolic phenotypes with coronary artery disease and cardiovascular events in patients with stable chest pain","volume":"44","author":"Kammerlander","year":"2021","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5120\/11430-6785","article-title":"K-means with three different distance metrics","volume":"67","author":"Singh","year":"2013","journal-title":"Int J Comput Appl"},{"key":"B27","volume-title":"Guideline on Haemoglobin Cutoffs to Define Anaemia in Individuals and Populations","year":"2024"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1743679","article-title":"Association of geriatric nutritional risk index with metabolic dysfunction-associated steatotic liver disease and subtypes in Chinese elderly: identification of an overnutrition risk threshold and implications for extended risk stratification","volume":"13","author":"Guo","year":"2026","journal-title":"Front Nutr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","article-title":"Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease","volume":"23","author":"Chen","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03272-3","article-title":"Integrating lipometabolic and adiposity indices to enhance risk stratification for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: clinical utility and interplay between triglyceride-glucose body mass index and low-density lipoprotein cholesterol","volume":"25","author":"Yang","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12933-026-03205-0","article-title":"Evaluation of the lipid accumulation product for odds of MASLD stratification in type 2 diabetes: establishing sex-specific thresholds and clinical utility","volume":"25","author":"Qu","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2026.117826","article-title":"Suppression of hepatic PPAR\u03b1 by hypoxia disrupts cholesterol metabolism and indirectly impairs arterial endothelial function in MASLD","volume":"248","author":"Bao","year":"2026","journal-title":"Biochem Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00109-023-02308-5","article-title":"The role of hypoxia-inducible factor 1\u03b1 in hepatic lipid metabolism","volume":"101","author":"Luo","year":"2023","journal-title":"J Mol Med (Berl)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2022.100177","article-title":"Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents","volume":"14","author":"Hazlehurst","year":"2022","journal-title":"Metabol Open"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2014.01.033","article-title":"HIF-1\u03b1 and HIF-2\u03b1 are critically involved in hypoxia-induced lipid accumulation in hepatocytes through reducing PGC-1\u03b1-mediated fatty acid \u03b2-oxidation","volume":"226","author":"Liu","year":"2014","journal-title":"Toxicol Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00052.2019","article-title":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2\u03b1\/PPAR\u03b1 pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-024-01068-5","article-title":"Eliminating senescent cells by white adipose tissue-targeted senotherapy alleviates age-related hepatic steatosis through decreasing lipolysis","volume":"46","author":"Tang","year":"2024","journal-title":"Geroscience"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjae039","article-title":"Hypoxia signaling in the adipose tissue","volume":"16","author":"Huynh","year":"2025","journal-title":"J Mol Cell Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9100966","article-title":"The universal soldier: enzymatic and non-enzymatic antioxidant functions of serum albumin","volume":"9","author":"Belinskaia","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910318","article-title":"Serum albumin in health and disease: esterase, antioxidant, transporting and signaling properties","volume":"22","author":"Belinskaia","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1952423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:52:01Z","timestamp":1790743921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1952423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":41,"alternative-id":["10.3389\/fendo.2026.1952423"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1952423","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1952423"}}